Source: GlobeNewswire Inc.
A securities fraud class action lawsuit has been filed against The Chemours Company (NYSE: CC) for allegedly making materially false statements about the reliability of its financial guidance. The lawsuit covers investors who purchased CC securities between February 20, 2026 and August 4, 2026. The company allegedly overstated aftermarket demand for its Opteon refrigeration products, leading to a significant stock price decline of 18.63% on August 5, 2026, after the company reduced its full-year adjusted EBITDA guidance.
Source: GlobeNewswire Inc.
ClaimsFiler reminds investors with losses exceeding $100,000 that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company. The lawsuit alleges that Chemours and its executives failed to disclose material information about channel oversupply during the Class Period (February 20 - August 4, 2026). The company cut its full-year adjusted EBITDA guidance significantly, causing its stock to fall 18.63% on August 5, 2026.
Source: GlobeNewswire Inc.
A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.
Source: Zacks Investment Research
The Chemours Company (CC) is drawing attention due to high implied volatility in its October 2026 put options, suggesting traders expect significant price movement. However, the fundamental outlook is weak, with Chemours holding a Zacks Rank #4 (Sell) rating and analysts cutting earnings estimates from 49 cents to 26 cents per share over the last 60 days. The high implied volatility may present an opportunity for options traders to sell premium and capture decay.
Source: GlobeNewswire Inc.
The global high-performance fluoropolymers market is projected to grow from USD 5.17 billion in 2026 to USD 7.82 billion by 2032 at a CAGR of 7.11%, driven by semiconductor fabrication, electric vehicle electrification, battery technology, and hydrogen infrastructure demands. Key growth factors include regulatory compliance requirements, AI-driven innovation in materials discovery, and expanding applications across aerospace, medical devices, and industrial coatings.
Source: GlobeNewswire Inc.
Pomerantz LLP is investigating potential securities fraud claims against The Chemours Company following the company's August 4, 2026 announcement of reduced full-year EBITDA guidance ($775M-$825M from $800M-$900M) and management's admission of channel oversupply issues. Chemours stock fell 18.63% on August 10, 2026, following the disclosure that approximately $65 million in aftermarket sales were misallocated.
Source: GlobeNewswire Inc.
Pomerantz Law Firm has filed class action lawsuits against Blaize Holdings, Inc. and is investigating claims against Rackspace Technology and The Chemours Company. The Blaize lawsuit stems from allegations of securities fraud related to a purported deal with NeoTensr, a 4-month-old company with allegedly photoshopped product images. Following a short report by Pelican Way Research on April 28, 2026, Blaize's stock fell 12.04%. Investors have until October 5, 2026, to join the class action.
Source: GlobeNewswire Inc.
Pomerantz Law Firm has filed class action lawsuits against Planet Fitness, Rackspace Technology, and The Chemours Company, alleging securities fraud and unlawful business practices. Planet Fitness saw a significant stock price decline of 31.19% on May 7, 2026, following disappointing Q1 2026 results and reduced full-year guidance. Investors have until September 14, 2026, to join the class action.